Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studies.

导出 LinkOut

翻译打印收藏纠错

作者： Diego,Kauffmann-Guerrero ^[1] ; Zulfiya,Syunyaeva ^[1] ; Kathrin,Kahnert ^[1] ; Amanda,Tufman ^[1]

作者单位： Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V and Thoracic Oncology Centre Munich, University of Munich (LMU), Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Munich, Germany. ^[1]

关键词 Non-small cell lung cancer (NSCLC)chemotherapy epidermal growth factor receptor mutation (EGFR mutation)tyrosine-kinase inhibitor resistance (TKI resistance)

DOI 10.21037/acr.2019.09.02

PMID 31728434

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

AME case reports

2019年3卷

36页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studies.

AME case reports

相似文献

AME case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Excellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studies.

AME case reports

相似文献

AME case reports

相关期刊

检索历史清除